Cargando…
Glutamatergic augmentation strategies in obsessive–compulsive disorder
Proven treatment strategies for obsessive–compulsive disorder (OCD) include pharmacotherapy with serotonin reuptake inhibitors and cognitive behavior therapy (CBT). A significant proportion of patients (25%–30%) fail to respond to these treatment options, necessitating the need for additional treatm...
Autores principales: | Sheshachala, Karthik, Narayanaswamy, Janardhanan C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343415/ https://www.ncbi.nlm.nih.gov/pubmed/30745678 http://dx.doi.org/10.4103/psychiatry.IndianJPsychiatry_520_18 |
Ejemplares similares
-
Investigating the Role of Glutamate in Obsessive-Compulsive Disorder: Current Perspectives
por: Karthik, Sheshachala, et al.
Publicado: (2020) -
Noninvasive brain stimulation in obsessive–compulsive disorder
por: Shivakumar, Venkataram, et al.
Publicado: (2019) -
Recent advances in obsessive compulsive and related disorders
por: Narayanaswamy, Janardhanan C., et al.
Publicado: (2019) -
Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder
por: Ting, Jonathan T, et al.
Publicado: (2008) -
Neuroimaging findings in obsessive–compulsive disorder: A narrative review to elucidate neurobiological underpinnings
por: Hazari, Nandita, et al.
Publicado: (2019)